The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goodyear, C. S.
Right arrow Articles by Silverman, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodyear, C. S.
Right arrow Articles by Silverman, G. J.
The Journal of Immunology, 2007, 178: 2636-2640.
Copyright © 2007 by The American Association of Immunologists, Inc.


CUTTING EDGE

Cutting Edge: Bim Is Required for Superantigen-Mediated B Cell Death1

Carl S. Goodyear2,3, Maripat Corr, Fujimi Sugiyama2, David L. Boyle and Gregg J. Silverman3

Rheumatic Diseases Core Center, University of California, San Diego, La Jolla, CA 92093

To impair B cell clonal regulation, the microbial virulence factor, protein A of Staphylococcus aureus, can interact with evolutionarily conserved BCR-binding sites to induce a form of Fas-independent activation-associated B cell death that results in selective immune tolerance. We now show that this in vivo death pathway is associated with induction of increased transcript and protein levels of Bim, a BH3-only proapoptotic Bcl-2 family protein, which is inhibited by excess B cell-activating factor. An absolute requirement for Bim was documented, since Bim-deficient B cells were protected from in vivo superantigen-induced death and instead underwent persistent massive supraclonal expansion without functional impairment. These studies characterize a BCR-dependent negative clonal selection pathway that has been co-opted by a common bacterial pathogen to induce selective defects in host immune defenses.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Grants CA104815 from the National Cancer Institute and National Blood Foundation (to C.S.G.), Grants AI40305, AR47360, AR50659, and AI46637 from the National Institutes of Health, and grants from the Alliance for Lupus Research (to G.J.S.).

2 Current address: Division of Clinical Neurosciences, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, G12 8TA, UK.

3 Address correspondence and reprint requests to Dr. Carl S. Goodyear, at the current address: Glasgow Biomedical Research Centre, B329, University of Glasgow, 120 University Place, Glasgow, G12 8TA, U.K. or Dr. Gregg J. Silverman, Rheumatic Diseases Core Center, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0663. E-mail addresses: C.Goodyear{at}clinmed.gla.ac.uk or gsilverman{at}ucsd.edu

4 Abbreviations used in this paper: SpA, protein A of Staphylococcus aureus; AICD, activation-induced cell death; BAFF, B cell activation-induced factor of the TNF family; LN, lymph node; {Delta}{Psi}m, mitochondrial membrane potential; SAg, superantigen.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Nishiyama, S. Planque, Y. Mitsuda, G. Nitti, H. Taguchi, L. Jin, J. Symersky, S. Boivin, M. Sienczyk, M. Salas, et al.
Toward Effective HIV Vaccination: INDUCTION OF BINARY EPITOPE REACTIVE ANTIBODIES WITH BROAD HIV NEUTRALIZING ACTIVITY
J. Biol. Chem., October 30, 2009; 284(44): 30627 - 30642.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Butler, N. Wertz, P. Weber, and K. M. Lager
Porcine Reproductive and Respiratory Syndrome Virus Subverts Repertoire Development by Proliferation of Germline-Encoded B Cells of All Isotypes Bearing Hydrophobic Heavy Chain CDR3
J. Immunol., February 15, 2008; 180(4): 2347 - 2356.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.